Vutrisiran – July 2026

  • Brand names:
    • Amvuttra®
  • Pharmaceutical Company:
    • MEDISON PHARMA AUSTRALIA PTY LIMITED
  • Condition/Indication: Transthyretin amyloid cardiomyopathy (ATTR-CM)
  • Meeting Date: July 2026
Public Summary Documents
Last updated
13 November 2026